VTRS

Viatris Inc

Health Care · Pharmaceuticals

$211.99 sample

+1.89 (+0.90%) 1D

Market cap

$155.1B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-12

Alerts

8

Price$211.99 +10.49% 3M daily closessample

211.99178.65

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12SEC10-Q filed
Oct 06SEC10-Q filed
Oct 01INSInsider buy: Chief Executive Officer
Sep 28INSInsider sell: 10% owner
Sep 18INSInsider sell: Chief Executive Officer
Sep 10SEC8-K filed: material event
Sep 07INSInsider buy: Chief Executive Officer
Sep 02INSInsider sell: EVP, Operations

Sign up to see the real VTRS record →

Company facts

SEC EDGAR registration

Name: Viatris Inc
Sector: Health Care
Industry: Pharmaceuticals
Smart-money score: +52sample, -100 to +100
Reporting currency: USD

Who is positioning in VTRS

sample

Insiders: 24 insider transactions over 90 days, net selling, $42.1M
Congress: 3 members traded over 90 days
Institutions · 13F: 5 funds hold $2.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$7.3B +13.9% y/y

Q4 2024Q3 2026

Inventory$4.4B +12.4% y/y

Q4 2024Q3 2026

Accounts receivable$3.3B +13.5% y/y

Q4 2024Q3 2026

Total debt$8.8B +18.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $106.0B +1.0% 3M
Sample peer B: $137.3B +16.1% 3M
Sample peer C: $36.7B +15.1% 3M
Sample peer D: $29.0B -1.7% 3M
Sample peer E: $75.6B -7.6% 3M